China Health Group (FRA:VNL1) ROE % Adjusted to Book Value: -82.06% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:VNL1 China Health Group Inc FRA:VNL1
42 GF Score
Price €0.00
! 4 Warning Signs
View Full Analysis

What is China Health Group ROE % Adjusted to Book Value?

China Health Group FRA:VNL1 42 ROE % Adjusted to Book Value is -82.06% as of Dec. 2025. GuruFocus rates FRA:VNL1 with a GF Score™ of 42/100. The stock has 4 warning signs investors should review.

China Health Group's ROE % for the quarter that ended in Dec. 2025 was -70.57%. China Health Group's PB Ratio for the quarter that ended in Dec. 2025 was 0.86. China Health Group's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 was -82.06%.

China Health Group ROE % Adjusted to Book Value Related Terms

China Health Group ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for China Health Group's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China Health Group ROE % Adjusted to Book Value Chart

China Health Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.60 -8.66 -109.78 -14.23 -26.45

China Health Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -243.42 127.69 -41.03 27.96 -82.06

FRA:VNL1 vs TMO, DHR, IDXX: ROE % Adjusted to Book Value Comparison

For the Diagnostics & Research subindustry, China Health Group's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

China Health Group ROE % Adjusted to Book Value vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, China Health Group's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where China Health Group's ROE % Adjusted to Book Value falls into.


FRA:VNL1
42GF Score
China Health Group Inc FRA:VNL1
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

China Health Group ROE % Adjusted to Book Value Calculation

China Health Group's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-22.75% / 0.86
=-26.45%

China Health Group's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-70.57% / 0.86
=-82.06%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of -82.06% mean?
China Health Group (FRA:VNL1) has a ROE % Adjusted to Book Value of -82.06% as of Dec. 2025. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on China Health Group and its competitors.
Is China Health Group's ROE % Adjusted to Book Value too high?
China Health Group's current ROE % Adjusted to Book Value is -82.06%. Overall, China Health Group has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does China Health Group's ROE % Adjusted to Book Value compare to TMO and DHR?
China Health Group's ROE % Adjusted to Book Value of -82.06% can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Medical Diagnostics & Research company?
A good ROE % Adjusted to Book Value depends on the Medical Diagnostics & Research industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on China Health Group and its competitors. China Health Group's current ROE % Adjusted to Book Value is -82.06%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Health Group stock overvalued right now?
China Health Group (FRA:VNL1) has a current ROE % Adjusted to Book Value of -82.06%. The current ROE % Adjusted to Book Value is -82.06%. China Health Group's overall GF Score™ is 42/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For China Health Group (FRA:VNL1), the current ROE % Adjusted to Book Value is -82.06% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

China Health Group Business Description

Other Exchanges 08225:Hong Kong
Address Building 17, Jianwai SOHO, Chaoyang District, Beijing, CHN
China Health Group Inc is an investment holding company engaged in providing medical care facilities in the People's Republic of China. The company provides provision of post-launch market research, medical and medical market services (PM services), Provision of contracted pharmaceutical development services (PD services), Provision of contracted clinical research services (CR Services), drug technologies, and Other medical services. The majority of its revenue for the company comes from the provision of PM services.
42GF Score

Get the complete analysis for FRA:VNL1

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.00
Price